Postdoc - Targeting Allergic Hypersensitivity

The Department of Biomedicine (DBM) integrates basic and clinical researchers from University of Basel and University Hospitals committed to deepen the understanding of health and disease while driving the development of innovative therapies that address unmet medical needs.
With over 70 research groups and 800 employees, the Department of Biomedicine is the largest department within the University of Basel. Be part of our future!

 
The Wymann lab at the DBM Mattenstrasse, University of Basel, Switzerland, invites qualified candidates to apply for a post-doctoral position in Biomedical Research investigating allergic, immunologic and metabolic processes. The candidate will join a multi-disciplinary team focusing on the elucidation and targeting of major stress and lipid kinase signaling pathways in allergic hypersensitivity, allergy, chronic inflammation and cancer. Besides performing biochemical, cellular and mouse genetic studies, the candidate interacts with Chemists developing novel bioactive small molecules targeting relevant signaling nodes in the mentioned pathologies.
 
The working place of the successful candidate is the Department of Biomedicine at Mattenstrasse 28, 4057 Basel.
 
Project:
The aim of the project is to elucidate molecular intra- and extracellular mechanisms of signaling modulating myeloid cells' immune responses. The project is supported by Innosuisse and has a translational goal aiming to pave a path to clinical applications.

This project is flanked by basic research projects

i) investigating of the role of phosphoinositide 3-kinase (PI3K) signaling in allergy, metabolic control, obesity, diabetes and cancer; see https://data.snf.ch/grants/grant/189065
ii) developing and validation of novel chemical probes and degraders to dissect mechanisms of adverse effects in cancer and metabolism. For a summary of the latter see: https://data.snf.ch/grants?q=204602

• Elucidating signal transduction involving GPCR, cytokine-, immunoglobulin downstream signaling involved in an inflammatory and metabolic network.
• Functional immune cell / phenotypic / response output assays and biomarker detection /identification in vitro and in vivo.
• Determining immune cell responses via FACS, high content imaging microscopy, proteomics and transcriptomics and more.
• Identification of targetable signaling nodes in the above pathways.
• Set-up of in vitro and in vivo validation workflows for novel small molecules.
• Writing of scientific publications, patents and regulatory reports.
• Personal career and leadership development, mentoring of students and collaborators.

The successful candidate holds a PhD in Biochemistry, Molecular Biology, Immunology or another relevant Life-Science degree. Expertise in immunology, allergy, FACS (analysis and cell sorting), and mouse models is required. The candidate should hold a LTK module 1 (rodent course, Switzerland) or a FELASA function A/C/D (EU) certificate, including the required associated continued formation.
The candidate has an excellent proven track record in the publication of peer-reviewed scientific articles and/or patents.
University of Basel is an equal opportunity employer. Salaries are according to the staff-regulations and depend on the qualifications and experience of the candidate.
Application / Contact

Please submit your resume (CV), a letter of motivation, a putative career plan, diplomas, and addresses of 2-3 references to the UniBas jobs portal at https://jobs.unibas.ch/?lang=en (if you are on it, see button below). Application via the https://jobs.unibas.ch/?lang=en platform is mandatory, applications by Email will not be considered. When on the portal enter the search terms “wymann lab" or “hypersensitivity".